Tesla recalls nearly 6,000 cars over potentially loose bolts : Bulletin: Business Today
Business Today

Tesla recalls nearly 6,000 cars over potentially loose bolts

Loading the player...

Shailendra Shukla | June 5, 2021

'Publicity': Delhi HC junks Juhi Chawla's suit against 5G; imposes Rs 20-lakh fine

The Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country. The court ruled the plea was filed to gain "publicity" and that the plaintiffs, Chawla and two others, have abused the process of law. The Delhi High Court has imposed a fine of Rs 20 lakh on the plaintiffs. After the court pronounced the judgement, Chawla's counsel sought a stay on the verdict. This request was outrightly rejected by the Delhi High Court.

Tesla recalls nearly 6,000 cars over potentially loose bolts

Tesla Inc is recalling nearly 6,000 US vehicles because brake caliper bolts could be loose, with the potential to cause a loss of tire pressure, documents made public on Wednesday show. The recall covers certain 2019-2021 Model 3 vehicles and 2020-2021 Model Y vehicles. Tesla's filing with the National Highway Traffic Safety Administration (NHTSA) said it had no reports of crashes or injuries related to the issue and that the company will inspect and tighten, or replace, the caliper bolts as necessary.

Delta variant behind spike in COVID-19 cases in second wave: Govt study

A recent study conducted by scientists of INSACOG and the National Centre for Disease Control (NCDC) has shown that despite having a high seropositivity rate of 56 per cent, people of Delhi got little protection against the Delta variant of the coronavirus that took over the national capital in March 2021 causing an unprecedented rise in cases. The study was focused on determining the reason behind the second wave of the COVID-19 pandemic which swept much of North India. The study stated that the B.1.617 variant (Delta) and its lineage B.1.617.2 were primarily responsible for the surge in COVID-19 cases.

DCGI approves Serum's request to manufacture Sputnik V COVID-19 vaccine in India

The Drugs Controller General of India (DGCI) on Friday granted permission to the Serum Institute of India (SII) to manufacture the Russian Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, according to official sources. Pune-based SII has partnered with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V COVID-19 vaccine in India at its licensed facility in Hadapsar. The licence granted to SII will remain enforced for a period of three years from June 4 onwards unless it is suspended or revoked.

Amphotericin B not the only cure available for black fungus: ICMR

The Indian Council of Medical Research (ICMR) informed the Delhi High Court on Friday that Liposomal Amphotericin B is not the only medication available for the treatment of mucormycosis, also called black fungus. ICMR said it while submitting a policy on the distribution of the said drug for treating black fungus. The apex health research body further told the court that other amphotericin formulations are also available and can be used with "supplementary medicines to reduce toxic effects."

More from this section